background
middl
east
respiratori
syndrom
coronaviru
merscov
caus
pneumonia
rel
high
case
fatal
rate
human
smoker
chronic
obstruct
pulmonari
diseas
copd
patient
report
suscept
merscov
infect
determin
express
merscov
receptor
dipeptidyl
peptidas
iv
lung
tissu
smoker
without
airflow
limit
copd
patient
comparison
nonsmok
individu
neversmok
method
express
measur
lung
tissu
lung
resect
specimen
neversmok
smoker
without
airflow
limit
copd
gold
stage
ii
patient
lung
explant
endstag
copd
patient
control
subject
copd
patient
well
phenotyp
agematch
mrna
express
determin
use
qrtpcr
protein
express
quantifi
use
immunohistochemistri
result
smoker
subject
copd
mrna
protein
express
significantli
higher
compar
neversmok
addit
found
mrna
protein
express
invers
correl
lung
function
diffus
capac
paramet
conclus
provid
evid
upregul
lung
smoker
copd
patient
could
partial
explain
individu
suscept
merscov
infect
data
also
highlight
possibl
role
copd
pathogenesi
keyword
middl
east
respiratori
syndrom
coronaviru
merscov
dipeptidyl
peptidas
smoke
chronic
obstruct
pulmonari
diseas
copd
middl
east
respiratori
syndrom
coronaviru
merscov
newli
emerg
pathogen
mainli
caus
pneumonia
rel
high
casefat
rate
sinc
laboratoryconfirm
case
report
world
health
organ
major
case
occur
famili
hospitalrel
cluster
humantohuman
transmiss
clinic
cours
merscov
infect
rang
asymptomat
acut
respiratori
distress
syndrom
need
ventilatori
support
infect
host
merscov
attach
receptor
exopeptidas
call
dipeptidyl
peptidas
also
known
type
ii
transmembran
glycoprotein
express
mani
cell
type
organ
bodi
serv
multipl
function
among
posttransl
cleavag
hormon
chemokin
tcell
activ
cell
adhes
apoptosi
lung
howev
express
minimum
level
mainli
alveolar
epitheli
cell
endotheli
cell
lesser
extent
bronchiolar
epitheli
cell
airway
submucos
gland
alveolar
macrophag
lymphocyt
plasmacytoid
dendrit
cell
importantli
alveolar
epitheli
cell
main
target
merscov
sever
underli
comorbid
includ
chronic
lung
diseas
report
increas
risk
acquir
merscov
infect
chronic
obstruct
pulmonari
diseas
copd
highli
preval
chronic
lung
diseas
older
subject
current
lead
caus
death
worldwid
common
caus
copd
chronic
cigarett
smoke
inflammatori
respons
cigarett
smoke
result
excess
releas
chemokin
cytokin
subsequ
high
influx
immun
cell
smoke
also
report
increas
suscept
merscov
infect
aim
investig
express
merscov
receptor
larg
wellphenotyp
cohort
smoker
without
airflow
limit
comparison
agematch
individu
never
smoke
neversmok
lung
resect
specimen
obtain
patient
diagnos
solitari
pulmonari
tumor
ghent
univers
hospit
ghent
belgium
explant
lung
endstag
copd
patient
uz
gasthuisberg
leuven
belgium
base
preoper
spirometri
diffus
capac
test
questionnair
patient
categor
neversmok
normal
lung
function
smoker
without
airflow
limit
patient
copd
copd
sever
defin
accord
global
initi
chronic
obstruct
lung
diseas
gold
classif
none
patient
treat
neoadjuv
chemotherapi
lung
tissu
patient
diagnos
solitari
pulmonari
tumor
obtain
maximum
distanc
pulmonari
lesion
without
sign
retroobstruct
pneumonia
tumor
invas
collect
pathologist
lung
tissu
patient
copd
gold
iiiiv
obtain
lung
explant
endstag
copd
patient
undergo
lung
transplant
written
inform
consent
obtain
subject
studi
approv
medic
ethic
committe
ghent
univers
hospit
univers
hospit
gasthuisberg
leuven
patient
characterist
list
tabl
detail
patient
characterist
per
readout
provid
supplementari
tabl
biopsi
sampl
proxim
bronchi
obtain
patient
male
femal
moderatetosever
copd
previous
recruit
separ
studi
inclus
criteria
follow
chronic
product
cough
age
year
current
smoker
neg
skin
test
inhal
allergen
fev
predict
normal
valu
fev
vc
revers
fev
pred
terbutalin
inhal
suffer
moderatetosever
bronchial
hyperrespons
determin
pc
valu
upon
challeng
histamin
methacholin
exclus
criteria
histori
asthma
complaint
wheez
recent
respiratori
tract
infect
recent
concurr
usag
antiinflammatori
drug
oral
antiinflammatori
medic
discontinu
least
month
inhal
glucocorticoid
least
week
start
studi
bronchoscopi
perform
olympu
bf
least
biopsi
taken
bronchi
right
left
upper
lower
lobe
use
fenestr
forcep
accord
publish
guidelin
studi
approv
medic
ethic
committe
erasmu
univers
medic
center
rotterdam
written
inform
consent
obtain
particip
patient
characterist
list
tabl
proxim
bronchi
biopsi
sampl
healthi
individu
male
femal
previous
describ
earlier
studi
use
neg
control
tabl
provid
overview
differ
cohort
sampl
use
studi
lung
dendrit
cell
dc
isol
singl
cell
suspens
lung
tissu
patient
describ
previous
lung
tissu
rins
cut
small
fragment
incub
digest
medium
next
sampl
resuspend
pb
contain
mm
edta
pass
filter
subsequ
pulmonari
mononuclear
cell
separ
ficol
densiti
gradient
cell
label
sort
facsaria
bd
bioscienc
rna
extract
polymeras
chain
reaction
pcr
analysi
lung
tissu
perform
describ
previous
rna
extract
lung
tissu
block
subject
neversmok
smoker
without
airflow
limit
patient
copd
gold
ii
patient
copd
gold
iv
perform
mirneasi
mini
kit
qiagen
hilden
germani
follow
manufactur
instruct
next
complementari
dna
cdna
prepar
advanc
cdna
synthesi
kit
rtqpcr
biorad
hercul
california
taqman
gene
express
assay
appli
biosystem
forster
citi
california
use
measur
express
refer
gene
dehydrogenas
gapdh
hypoxanthin
succin
dehydrogenas
complex
flavoprotein
subunit
sdha
data
analyz
use
standard
curv
method
express
calcul
rel
express
refer
gene
use
genorm
applet
accord
guidelin
theoret
framework
previous
describ
human
lung
dc
subset
rna
extract
perform
mirneasi
mini
kit
qiagen
hilden
germani
wherea
rna
amplif
qiagen
quantitect
whole
transcriptom
kit
follow
manufactur
instruct
express
dc
subset
calcul
rel
express
gapdh
peptidylprolyl
isomeras
ppia
describ
previous
section
obtain
formalinfix
paraffinembed
lung
tissu
block
subject
neversmok
smoker
without
copd
subject
copd
gold
ii
subject
copd
gold
iiiiv
incub
antibodi
polyclon
goatantihuman
r
system
antigen
retriev
citrat
buffer
klinipath
olen
belgium
next
slide
color
diaminobenzidin
dako
carpinteria
california
counterstain
mayer
hematoxylin
sigmaaldrich
stloui
missouri
isotyp
control
goat
immunoglobulin
g
igg
r
system
abingdon
uk
costain
alveolar
epitheli
cell
antiaquaporin
abcam
cambridg
uk
prosurfact
c
abcam
use
detect
respect
type
type
ii
alveolar
cell
subsequ
color
vector
blue
vector
peterborough
uk
quantit
score
amount
score
alveolar
tissu
airway
epithelium
perform
use
axiovis
softwar
zeiss
oberkochen
germani
order
measur
area
signal
alveolar
tissu
imag
alveolar
tissu
record
averag
tissu
block
per
patient
intens
brown
stain
wish
score
select
mean
select
specif
hue
light
satur
valu
hue
satur
light
valu
ident
imag
therefor
restrict
score
specif
signal
everi
imag
alveolar
tissu
select
signal
calcul
within
alveolar
tissu
normal
area
alveolar
tissu
present
imag
final
score
patient
averag
ratio
signal
imag
airway
epithelium
amount
signal
normal
length
basement
membran
pbm
final
score
patient
averag
stain
airway
present
tissu
block
avail
patient
number
airway
per
patient
studi
use
resect
lung
tissu
patient
underw
lobectomia
pneumectomia
due
lung
cancer
explant
lung
tissu
endstag
copd
patient
bronchial
biopsi
tissu
patient
abbrevi
copd
chronic
obstruct
pulmonari
diseas
gold
global
initi
chronic
obstruct
lung
diseas
ihc
immunohistochemistri
qrtpcr
quantit
reversetranscript
polymeras
chain
reaction
detect
frozen
sampl
proxim
bronchi
perform
mous
monoclon
antibodi
santa
cruz
biotechnolog
dalla
texa
previous
fix
aceton
incub
normal
goat
serum
dako
glostrup
denmark
hour
room
temperatur
slide
subsequ
stain
biotinyl
goat
antimous
ig
serum
pbsbsa
plu
human
serum
streptavidin
alkalin
phosphatas
pb
bsa
plu
human
serum
biogenex
klinipath
duiven
netherland
minut
posit
signal
reveal
new
fuchsin
substrat
chroma
kongen
germani
counterstain
perform
gill
hematoxylin
neg
control
stain
perform
substitut
primari
monoclon
antibodi
isotyp
antibodi
statist
analysi
perform
sigma
stat
softwar
spss
chicago
illinoi
use
kruskalw
mannwhitney
u
fisher
exact
test
spearman
correl
analysi
addit
oneway
analysi
varianc
anova
ttest
use
statist
analys
dc
subset
characterist
studi
popul
present
median
interquartil
rang
differ
pvalu
consid
signific
p
p
p
messeng
rna
mrna
express
analyz
lung
tissu
subject
lung
tissu
deriv
either
resect
tissu
lobectomi
never
smoker
smoker
without
airflow
limit
patient
copd
gold
stage
ii
explant
lung
lung
transplant
patient
copd
gold
stage
iiiiv
patient
characterist
describ
supplementari
tabl
compar
neversmok
mrna
express
lung
tissu
smoker
without
airflow
limit
patient
copd
significantli
increas
figur
moreov
mrna
express
lung
tissu
patient
copd
gold
stage
iiiiv
significantli
higher
lung
tissu
smoker
without
airflow
limit
patient
copd
gold
stage
ii
figur
quantif
accord
smoke
statu
exv
current
smoker
shown
supplementari
figur
furthermor
mrna
express
invers
correl
sever
airflow
limit
fev
r
p
fev
fvc
ratio
r
p
figur
addit
mrna
express
also
correl
invers
diffus
capac
lung
dlco
r
p
kco
r
p
figur
linear
regress
analysi
reveal
associ
mrna
express
presenc
copd
signific
even
correct
age
sex
packyear
use
inhal
corticosteroid
supplementari
tabl
addit
dendrit
cell
dc
play
crucial
role
antivir
immun
investig
whether
mrna
express
differ
dc
subset
three
dc
subset
sort
langerinposit
dc
dcsignposit
dc
plasmacytoid
dc
pdc
mrna
mere
detect
pdc
supplementari
figur
protein
express
studi
lung
tissu
neversmok
smoker
without
airflow
limit
copd
patient
use
immunohistochemistri
ihc
stain
detect
apic
surfac
bronchiolar
epithelium
alveolar
epitheli
cell
alveoli
observ
protein
gradual
increas
neversmok
copd
gold
stage
iiiiv
figur
addit
perform
immunohistochem
stain
aquaporin
marker
type
alveolar
epitheli
cell
prosurfact
c
marker
type
ii
alveolar
epitheli
cell
confirm
upregul
protein
mainli
contribut
alveolar
epitheli
cell
figur
l
contrast
increment
observ
bronchiolar
epithelium
figur
well
proxim
bronchial
epithelium
figur
furthermor
also
detect
endotheli
cell
alveolar
macrophag
immun
cell
submucos
region
airway
epithelium
lymphoid
aggreg
supplementari
figur
quantifi
signal
lung
tissu
subject
use
axiovis
softwar
zeiss
characterist
patient
present
supplementari
tabl
compar
neversmok
protein
express
significantli
increas
alveolar
epitheli
cell
smoker
patient
copd
protein
express
highest
patient
copd
gold
stage
iiiiv
figur
quantif
protein
express
accord
smoke
statu
exv
current
smoke
shown
supplementari
figur
similar
mrna
express
protein
also
invers
correl
lung
function
paramet
fev
r
p
fev
fvc
ratio
r
p
well
diffus
capac
paramet
dlco
r
p
kco
r
p
linear
regress
analysi
reveal
associ
alveolar
express
presenc
copd
signific
even
correct
age
gender
packyear
use
inhal
corticosteroid
supplementari
tabl
studi
investig
express
merscov
receptor
lung
tissu
smoker
without
airflow
limit
copd
patient
comparison
neversmok
previous
report
mainli
detect
alveolar
epitheli
cell
lung
main
target
merscov
infect
among
dendrit
cell
found
mrna
mainli
express
pdc
confirm
vitro
data
show
among
antigen
present
cell
pdc
produc
larg
amount
type
iii
interferon
upon
contact
merscov
importantli
provid
evid
upregul
lung
mrna
protein
level
copd
patient
also
smoker
indic
individu
may
suscept
merscov
support
smoke
copd
risk
factor
merscov
infect
result
line
recent
studi
describ
higher
express
lung
copd
patient
compar
control
subject
differ
age
studi
find
evid
upregul
bronchial
bronchiolar
epithelium
lung
smoker
copd
patient
suggest
upregul
pulmonari
epithelia
restrict
alveolar
epitheli
cell
previou
studi
shown
limitedli
express
bronchial
bronchiolar
epithelium
even
absent
apic
surfac
nasal
respiratori
olfactori
epithelium
human
futur
studi
need
assess
whether
upregul
specif
alveolar
epitheli
cell
also
occur
upper
respiratori
tract
epithelium
addit
import
alveolar
macrophag
pathogenesi
merscov
need
research
cell
also
express
patrol
alveoli
close
contact
alveolar
epitheli
cell
current
unclear
upregul
lung
smoker
copd
patient
sever
cytokin
report
upregul
vitro
instanc
could
upregul
protein
express
enzymat
activ
primari
human
endotheli
cell
wherea
interleukin
il
report
increas
mrna
express
human
primari
bronchial
epitheli
cell
hand
copd
pathogenesi
sever
cytokinessuch
superfamilyhav
describ
play
import
role
studi
need
identifi
cytokin
could
upregul
lung
influenc
copd
pathogenesi
also
show
mrna
protein
express
invers
correl
lung
function
diffus
capac
paramet
data
suggest
possibl
role
copd
pathogenesi
exopeptidas
respons
cleav
chemokin
alter
biolog
function
moreov
abl
activ
cell
induc
product
proinflammatori
cytokin
later
could
affect
develop
copd
furthermor
also
capabl
influenc
migrat
immun
cell
activ
deactiv
chemokin
inflammatori
tumor
environ
interestingli
solubl
serum
copd
patient
report
significantli
lower
compar
noncopd
control
remain
possibl
copd
patient
concentr
low
serum
high
lung
facilit
migrat
certain
immun
cell
lung
studi
sever
strength
first
includ
larg
number
patient
thoroughli
character
second
elimin
possibl
interfer
presenc
malign
patient
also
includ
lung
tissu
deriv
explant
lung
endstag
copd
patient
devoid
malign
possibl
limit
studi
might
sex
imbal
group
respect
male
predomin
copd
group
femal
predomin
neversmok
howev
note
linear
regress
analys
indic
sex
significantli
contribut
differ
express
membranebound
data
line
recent
analys
solubl
serum
patient
copd
versu
noncopd
control
indic
relationship
figur
protein
express
lung
tissu
smoker
copd
patient
protein
express
analyz
use
axiovis
softwar
zeiss
area
posit
signal
normal
total
area
cell
present
analyz
imag
protein
express
lung
smoker
copd
patient
significantli
higher
comparison
never
smoker
b
correl
alveolar
protein
express
postbronchodil
fev
valu
c
correl
alveolar
protein
express
postbronchodil
tiffeneau
index
fev
fvc
correl
alveolar
protein
express
dlco
diffus
capac
transfer
factor
lung
carbon
monoxid
e
correl
alveolar
protein
express
kco
carbon
monoxid
transfer
coeffici
p
p
abbrevi
copd
chronic
obstruct
pulmonari
diseas
sex
level
also
import
acknowledg
factor
relat
copd
could
contribut
increas
merscov
suscept
independ
instanc
copd
patient
mostli
advanc
age
prone
mani
pulmonari
infect
hospit
besid
copd
associ
system
inflamm
might
also
caus
insuffici
host
immun
respons
pathogen
conclus
smoke
common
etiolog
copd
data
highlight
associ
chronic
exposur
cigarett
smoke
upregul
lung
well
partial
explain
increas
suscept
smoker
copd
patient
merscov
infect
imper
tri
replic
observ
anim
model
order
dissect
molecular
pathway
upregul
lung
supplementari
materi
avail
clinic
infecti
diseas
onlin
consist
data
provid
author
benefit
reader
post
materi
copyedit
sole
respons
author
question
comment
address
correspond
author
